125 related articles for article (PubMed ID: 11800585)
1. Reduced NK activity in pulmonary tuberculosis patients with/without HIV infection: identifying the defective stage and studying the effect of interleukins on NK activity.
Nirmala R; Narayanan PR; Mathew R; Maran M; Deivanayagam CN
Tuberculosis (Edinb); 2001; 81(5-6):343-52. PubMed ID: 11800585
[TBL] [Abstract][Full Text] [Related]
2. Augumentation of natural killer activity with exogenous interleukins in patients with HIV and pulmonary tuberculosis coinfection.
Ramana Rao PV; Rajasekaran S; Raja A
AIDS Res Hum Retroviruses; 2008 Nov; 24(11):1435-43. PubMed ID: 19000024
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-12 (IL-12) augments cytolytic activity of natural killer cells toward Mycobacterium tuberculosis-infected human monocytes.
Denis M
Cell Immunol; 1994 Jul; 156(2):529-36. PubMed ID: 7913000
[TBL] [Abstract][Full Text] [Related]
4. Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.
Zhang R; Xu J; Hong K; Yuan L; Peng H; Tang H; Ma P; Zhang Y; Xing H; Ruan Y; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S9-17. PubMed ID: 18172398
[TBL] [Abstract][Full Text] [Related]
5. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric analysis of natural killer cell function as a clinical assay.
Hatam L; Schuval S; Bonagura VR
Cytometry; 1994 May; 16(1):59-68. PubMed ID: 8033735
[TBL] [Abstract][Full Text] [Related]
8. Interleukins 2 and 12 produce significant recovery of cytotoxic function in dibutyltin-exposed human natural killer cells.
Whalen MM; Walker L; Loganathan BG
Environ Res; 2002 Feb; 88(2):103-15. PubMed ID: 11908935
[TBL] [Abstract][Full Text] [Related]
9. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS.
Nikolaeva LG; Maystat TV; Pylypchuk VS; Volyanskii YL; Masyuk LA; Kutsyna GA
Int Immunopharmacol; 2008 Jun; 8(6):845-51. PubMed ID: 18442788
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection.
Barcelos W; Sathler-Avelar R; Martins-Filho OA; Carvalho BN; Guimarães TM; Miranda SS; Andrade HM; Oliveira MH; Toledo VP
Scand J Immunol; 2008 Jul; 68(1):92-102. PubMed ID: 18484953
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. Implementation of the EGFP-K562 flow cytometric NK test: determination of NK cytotoxic activity in healthy elderly volunteers before and after feeding.
Allegra S; Deleine C; Michael-Jubely R; Gryson C; Boirie Y; Kantakamalakul W; Vasson MP
Cytometry A; 2006 Sep; 69(9):992-8. PubMed ID: 16969797
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell activity in the systemic connective tissue diseases.
Gonzalez-Amaro R; Alcocer-Varela J; Alarcón-Segovia D
J Rheumatol; 1988 Aug; 15(8):1223-8. PubMed ID: 3263500
[TBL] [Abstract][Full Text] [Related]
15. [NK cells in patients during complex therapy of destructive pulmonary tuberculosis].
Gogebashvili NV; Nonikashvili MI
Probl Tuberk; 1989; (4):43-5. PubMed ID: 2734264
[TBL] [Abstract][Full Text] [Related]
16. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
[TBL] [Abstract][Full Text] [Related]
17. Cytokine production in NK and NKT cells from Mycobacterium tuberculosis infected patients.
Kulpraneet M; Sukwit S; Sumransurp K; Chuenchitra T; Santiwatanakul S; Srisurapanon S
Southeast Asian J Trop Med Public Health; 2007 Mar; 38(2):370-5. PubMed ID: 17539289
[TBL] [Abstract][Full Text] [Related]
18. [Relation between malnutrition and cell-mediated immunity in pulmonary tuberculosis].
Yoneda T
Kekkaku; 1989 Oct; 64(10):633-40. PubMed ID: 2811000
[TBL] [Abstract][Full Text] [Related]
19. Flow-cytometric assessment of lymphocyte cytokine production in tuberculosis.
García M; Vargas JA; Castejón R; Navas E; Durantez A
Tuberculosis (Edinb); 2002; 82(1):37-41. PubMed ID: 11914061
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell-mediated cytokine response among HIV-positive south Indians with pulmonary tuberculosis.
Ramana Rao PV; Rajasekaran S; Raja A
J Interferon Cytokine Res; 2010 Jan; 30(1):33-42. PubMed ID: 20028198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
